Recombinant Anti-M2 x Anti-TCR (Vβ8) Bispecific Antibody (scFv-Fc) (BSCFV-180)

Recombinant Anti-M2 x Anti-TCR (Vβ8) Bispecific Antibody (scFv-Fc) is formed by fusing two different scFv fragments to the hinge and Fc regions, in which the Fc region are engineered by KIH. Two of scFv moiety has the antibody variable domain of either anti-M2 specificity or anti-TCR (Vβ8) specificity, which produces bivalent IgG-like molecules with desired characteristics of intact antibodies. This BsAb can retarget T cells to virus-infected cells. It is designed for the research of Inﬂuenza virus infection therapy.

Datasheet INQUIRY

Specifications

Targets

M2 & TCR (Vβ8)

Type

scFv-Fc

Species Reactivity

Human

Application

FuncS; Promising therapeutic agent

Related Disease

Inﬂuenza virus infection

Targets

Target 1

Gene ID

956528

UniProt ID

P03428

Alternative Names

influenza virus M2 protein;M2

Target 2

TCR (Vβ8)

Gene ID

28588

Alternative Names

Trbv8; T cell receptor beta variable 8; TCR; T-cell receptor

Our products and services are for research use only, and not for use in diagnostic or therapeutic procedures.

Online Inquiry

Customer Reviews and Q&As

There are currently no customer reviews or questions for Recombinant Anti-M2 x Anti-TCR (Vβ8) Bispecific Antibody (scFv-Fc) (BSCFV-180). Click the button below to contact us or submit your feedback about this product.

Recombinant Anti-M2 x Anti-TCR (Vβ8) Bispecific Antibody (scFv-Fc) (CAT#: BSCFV-180)

Specifications

Targets

Customer Reviews and Q&As